• Home
  • Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.

Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.

Author List
Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K
Publication
Annals of internal medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/35283000
Publication Year
2019
PubMed ID
30597485
Publication Title
Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. Ann Intern Med. 2019 02 19; 170(4):221-229.